Short and long interpregnancy interval and the risk for pediatric obstructive sleep apnea in the offspring

Hila Rapaport Pasternak1, Eyal Sheiner2, Aviv Goldbart3

  • 1Joyce & Irving Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Pediatric Pulmonology
|December 31, 2020
PubMed

Insights

Long interpregnancy intervals (IPI) between births increase the risk of obstructive sleep apnea syndrome (OSAS) in offspring. This finding highlights the importance of optimal birth spacing for child health outcomes.

Area of Science:

  • Reproductive Health
  • Pediatric Health
  • Epidemiology

Background:

  • Interpregnancy interval (IPI) is the time between live birth and subsequent conception.
  • Short and long IPIs are linked to adverse perinatal outcomes.
  • Some perinatal outcomes are risk factors for childhood obstructive sleep apnea syndrome (OSAS).

Purpose of the Study:

  • To investigate the association between interpregnancy interval (IPI) and the risk of obstructive sleep apnea syndrome (OSAS) in offspring.
  • To analyze this association over a follow-up period of up to 18 years.

Main Methods:

  • Population-based cohort study including singleton live births from 1991-2014.
  • Offspring hospitalizations for OSAS up to age 18 were evaluated based on IPI length.
  • Kaplan-Meier curves and Cox regression models were used to assess OSAS incidence and adjust for confounders.

Main Results:

  • The study included 144,397 deliveries; 7.9% had a long IPI (>60 months).
  • OSAS hospitalization rates were significantly higher in the long IPI group (0.9%) compared to intermediate (0.7%) and short IPIs (0.6%).
  • Long IPI remained a significant risk factor for pediatric OSAS after adjusting for preterm delivery, maternal diabetes, smoking, and delivery mode (aHR=1.45).

Conclusions:

  • Children born after a long interpregnancy interval face an elevated risk of developing pediatric obstructive sleep apnea syndrome.
  • Optimal birth spacing may be crucial for mitigating the risk of OSAS in children.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
319
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
653
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
132
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
337